Cargando…

Advances in the treatment of type 2 diabetes: impact of dulaglutide

The purpose of this review is to provide a review of current data of the most recently approved glucagon-like peptide (GLP)-1-receptor agonist, dulaglutide, in the treatment of type 2 diabetes. To complete this, a PubMed search was performed to identify manuscripts published from 1947 to July 2015....

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Angela M, Trujillo, Jennifer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861603/
https://www.ncbi.nlm.nih.gov/pubmed/27217788
http://dx.doi.org/10.2147/DMSO.S75452

Ejemplares similares